This week, we're sitting down with John Faragon to discuss the BRIGHTE study, what it can tell us about fostemsavir, and why it's so important that this study was conducted for five years.

--
Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=QDN5045)